Histamine — Class II drug recall D-1069-2013
Terminated recall by Triangle Compounding, reported 2013-10-09, distributed in NC. Lack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract
| Recall number | D-1069-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Triangle Compounding, Cary, NC, United States |
| Recall initiated | 2013-09-06 |
| Classified | 2013-09-30 |
| Reported by FDA | 2013-10-09 |
| Terminated | 2025-04-23 |
| Distributed | NC |
| Quantity | 8 vials |
| Reason classes | microbial contamination, sterility |
| Lot numbers | 74651-LG4973 |
| Expiration dates | 2013-12-04 |
Product
Histamine, 10 ng/mL Injectable, MDV, Rx only, Triangle Compounding Pharmacy, 3700 Regency Parkway, Suite 140, Cary NC 27518.
Reason for recall
Lack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1069-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.